· By Sanofi Admin

For Maysoun Shomali, to #GoBoldly means researching life-saving therapies

Cropped Maysoun_GoBoldly_MTP_170128_4876

This post was authored by Maysoun Shomali, Scientist in Sanofi’s Oncology Research Therapeutic Area. Maysoun was recently featured in the Pharmaceutical Research and Manufacturers of America (PhRMA) GoBoldly campaign.
I was recently given the opportunity and great privilege to represent Sanofi US as part of PhRMA’s GoBoldly “Finishing Sentences” (aka “Together”) campaign. The campaign involves multiple […]

VIEW FULL POST
 · By Sanofi Admin

New Clinical Trials Website Educates and Empowers Patients

Many people would participate in a clinical trial but don’t understand what it involves or have misconceptions, so they don’t. To address this issue, Sanofi R&D created a patient-friendly educational website that explains what clinical trials are all about: the Clinical Study Guide (www.GuideToClinicalTrials.com). Clinical Sciences & Operation’s Lionel Bascles and Kristin Schuhwerk led the […]

VIEW FULL POST
 · By Sanofi Admin

Drug Development 101: Phase 3 Clinical Trials

This post was authored by Terttu Haring, Vice President in Clinical Sciences & Operations, Global Head Trial Operations, Sanofi
If you have been following along with our Drug Development 101 blog series, you will know that we shed light on preclinical research, Phase 1 clinical trials and Phase 2 clinical trials over the course of past […]

VIEW FULL POST
 · By Sanofi Admin

Sanofi Launches Digital Clinical Trials to Improve Recruitment and Reduce Trial Times

Science 37 Logo

Without clinical trials, new medicine may never make it from the research lab to patients in need. These carefully designed studies can provide important data that include proper dosage, benefit to patients, and potential side effects.
There is a growing challenge, however, in finding appropriate participants, especially for treatments that target highly specific conditions affecting narrower […]

VIEW FULL POST